During the past decade, Instituto Cancerologia Medellin; Clinica Las Americas conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Cancerologia Medellin; Clinica Las Americas" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Cancerologia Medellin; Clinica Las Americas" are "B-cell Lymphoma" (1 trials), "Blood Cancer" (1 trials), "Blood Disease" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Central Nervous System Complication" (1 trials). Many other conditions were trialed in "Instituto Cancerologia Medellin; Clinica Las Americas" in a lesser frequency.

Most popular intervention types in "Instituto Cancerologia Medellin; Clinica Las Americas" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Avelumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Cancerologia Medellin; Clinica Las Americas" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Cancerologia Medellin; Clinica Las Americas". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Cancerologia Medellin; Clinica Las Americas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Cancerologia Medellin; Clinica Las Americas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".